(Q37119417)

18 August 2017

1 reference

title

The once and future role of cytoreductive nephrectomy (English)

1 reference

18 August 2017

Mischel G Neill

1

1 reference

18 August 2017

Michael A S Jewett

series ordinal

2

1 reference

18 August 2017

publication date

14 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

26

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

346-352

1 reference

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Sorafenib in advanced clear-cell renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Nephrectomy for metastatic renal cell carcinoma: Indiana University experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Spontaneous regression of metastatic renal cancer. Case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Efficacy of multimodality therapy in advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.029

10.1016/J.UROLONC.2007.05.029

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference